Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results

PURPOSE: We performed a first-in-human clinical trial on ultrasound molecular imaging (USMI) in patients with breast and ovarian lesions using a clinical-grade contrast agent (kinase insert domain receptor [KDR] –targeted contrast microbubble [MB(KDR)]) that is targeted at the KDR, one of the key re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Willmann, Jürgen K., Bonomo, Lorenzo, Testa, Antonia Carla, Rinaldi, Pierluigi, Rindi, Guido, Valluru, Keerthi S., Petrone, Gianluigi, Martini, Maurizio, Lutz, Amelie M., Gambhir, Sanjiv S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5493049/
https://ncbi.nlm.nih.gov/pubmed/28291391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.8594
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados